Boxi Zhang

827 total citations
29 papers, 604 citations indexed

About

Boxi Zhang is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Boxi Zhang has authored 29 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Cancer Research. Recurrent topics in Boxi Zhang's work include Oral microbiology and periodontitis research (5 papers), Ubiquitin and proteasome pathways (5 papers) and Epigenetics and DNA Methylation (5 papers). Boxi Zhang is often cited by papers focused on Oral microbiology and periodontitis research (5 papers), Ubiquitin and proteasome pathways (5 papers) and Epigenetics and DNA Methylation (5 papers). Boxi Zhang collaborates with scholars based in Sweden, China and United States. Boxi Zhang's co-authors include Erik Norberg, Helin Vakifahmetoglu-Norberg, Amanda Tomie Ouchida, Gorbatchev Ambroise, Yuqing Hao, Adi Zheng, Per Hydbring, Torbjörn Bengtsson, Helin Vakifahmetoglu-Norberg and Hazem Khalaf and has published in prestigious journals such as Applied Physics Letters, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Boxi Zhang

26 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boxi Zhang Sweden 16 370 162 114 72 64 29 604
Albert V. Bitorina Netherlands 9 213 0.6× 102 0.6× 129 1.1× 45 0.6× 67 1.0× 14 506
Qingfeng Wang China 18 331 0.9× 101 0.6× 166 1.5× 73 1.0× 25 0.4× 65 800
Sarumathi Mohan United States 10 269 0.7× 88 0.5× 149 1.3× 80 1.1× 22 0.3× 11 669
Yen-Chang Hsiao Taiwan 17 281 0.8× 59 0.4× 41 0.4× 93 1.3× 17 0.3× 60 774
Dominick A. Scaramuzzino United States 9 272 0.7× 112 0.7× 67 0.6× 42 0.6× 51 0.8× 11 726
Zhilong Jia China 13 286 0.8× 108 0.7× 41 0.4× 26 0.4× 8 0.1× 29 519
Guoqing Hou China 12 337 0.9× 69 0.4× 44 0.4× 97 1.3× 14 0.2× 24 526
Hongjiang Wang China 16 762 2.1× 444 2.7× 52 0.5× 102 1.4× 23 0.4× 40 1.1k
Ju Youn Kim South Korea 10 189 0.5× 75 0.5× 218 1.9× 65 0.9× 60 0.9× 29 620
Shoichiro Kameoka Japan 8 459 1.2× 39 0.2× 214 1.9× 55 0.8× 76 1.2× 10 719

Countries citing papers authored by Boxi Zhang

Since Specialization
Citations

This map shows the geographic impact of Boxi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boxi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boxi Zhang more than expected).

Fields of papers citing papers by Boxi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boxi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boxi Zhang. The network helps show where Boxi Zhang may publish in the future.

Co-authorship network of co-authors of Boxi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Boxi Zhang. A scholar is included among the top collaborators of Boxi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boxi Zhang. Boxi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xun, Yong Shi, Boxi Zhang, et al.. (2025). Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors. EMBO Molecular Medicine. 17(4). 747–774. 1 indexed citations
2.
Zhang, Boxi, et al.. (2024). USP39 regulates pyruvate handling in non-small cell lung cancer. Cell Death Discovery. 10(1). 502–502.
3.
Zhang, Boxi, et al.. (2024). Deubiquitinase USP9x regulates the proline biosynthesis pathway in non-small cell lung cancer. Cell Death Discovery. 10(1). 342–342. 3 indexed citations
4.
Zhang, Boxi, et al.. (2022). A Method to Identify Potential Prognostic Markers Across Distinct Tumor Types. Methods in molecular biology. 2445. 275–288.
5.
Liu, Yuanyuan, et al.. (2022). Role of Thioredoxin-1 and its inducers in human health and diseases. European Journal of Pharmacology. 919. 174756–174756. 10 indexed citations
6.
Liu, Yuanyuan, et al.. (2022). Cold Stress Induced Liver Injury of Mice through Activated NLRP3/Caspase-1/GSDMD Pyroptosis Signaling Pathway. Biomolecules. 12(7). 927–927. 15 indexed citations
7.
Liu, Yuanyuan, et al.. (2021). Mogroside V Alleviates Lipopolysaccharide-Induced Neuroinflammation via Inhibition of TLR4-MyD88 and Activation of AKT/AMPK-Nrf2 Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 16 indexed citations
8.
Ma, Li, et al.. (2020). Isoorientin exerts a protective effect against 6-OHDA-induced neurotoxicity by activating the AMPK/AKT/Nrf2 signalling pathway. Food & Function. 11(12). 10774–10785. 24 indexed citations
9.
Zhang, Boxi, et al.. (2020). The deubiquitinase JOSD2 is a positive regulator of glucose metabolism. Cell Death and Differentiation. 28(3). 1091–1109. 29 indexed citations
10.
Zhang, Boxi, Dong Xu, Bingchang Zhang, et al.. (2020). Numerical investigation on the incipient motion of non-spherical sediment particles in bedload regime of open channel flows. Computational Particle Mechanics. 7(5). 987–1003. 20 indexed citations
11.
Lv, Hongming, et al.. (2020). The improvement effect of gastrodin on LPS/GalN-induced fulminant hepatitis via inhibiting inflammation and apoptosis and restoring autophagy. International Immunopharmacology. 85. 106627–106627. 23 indexed citations
12.
Ambroise, Gorbatchev, Tingting Yu, Boxi Zhang, et al.. (2020). Systematic analysis reveals a functional role for STAMBPL1 in the epithelial–mesenchymal transition process across multiple carcinomas. British Journal of Cancer. 123(7). 1164–1177. 16 indexed citations
13.
Ouchida, Amanda Tomie, Adi Zheng, Gorbatchev Ambroise, et al.. (2018). USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2. Biochemical and Biophysical Research Communications. 502(4). 429–434. 35 indexed citations
14.
Zhang, Boxi, Dawn E. Comstock, Yuqing Hao, et al.. (2018). miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas. Biochemical and Biophysical Research Communications. 499(2). 314–320. 23 indexed citations
15.
Zhang, Boxi, Adi Zheng, Per Hydbring, et al.. (2017). PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis. Cell Reports. 19(11). 2289–2303. 123 indexed citations
16.
Bengtsson, Torbjörn, et al.. (2017). Dual action of bacteriocin PLNC8 αβ through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation. Pathogens and Disease. 75(5). 12 indexed citations
17.
Zhang, Boxi, et al.. (2017). Characterization of the Role of the Malate Dehydrogenases to Lung Tumor Cell Survival. Journal of Cancer. 8(11). 2088–2096. 41 indexed citations
18.
Zhang, Boxi, Allan Sirsjö, Hazem Khalaf, & Torbjörn Bengtsson. (2016). Transcriptional profiling of human smooth muscle cells infected with gingipain and fimbriae mutants of Porphyromonas gingivalis. Scientific Reports. 6(1). 21911–21911. 6 indexed citations
19.
Zhang, Boxi. (2015). Modulaton of gene expression in human aortic smooth muscle cells by Porphyromonas gingivalis : a possible association between periodontitis and atherosclerosis. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026